AIM: To evaluate the clinicopathologic characteristics of patients with metastases to the gallbladder (MGBs). METHODS: We performed a single-center retrospective study of 20 patients with MGBs diagnosed pathologically from 1999 to 2007. RESULTS: Among 417 gallbladder (GB) malignancies, 20 (4.8%) were MGBs. The primary malignancies originated from the stomach (n = 8), colorectum (n = 3), liver (n = 2), kidney (n = 2), skin (n = 2), extrahepatic bile duct (n = 1), uterine cervix (n = 1), and appendix (n = 1). Twelve patients were diagnosed metachronously, presenting with cholecystitis (n = 4), abdominal pain (n = 2), jaundice (n = 1), weight loss (n = 1), and serum CA 19-9 elevation (n = 1); five patients were asymptomatic. The median survival after the diagnosis of MGB was 8.7 mo. On Cox regression analysis, R0 resection was the only factor associated with a prolonged survival [hazard ratio (HR): 0.01, P = 0.002]; presentation with cholecystitis was associated with poor survival (HR: 463.27, P = 0.006). CONCLUSION: MGBs accounted for 4.8% of all pathologically diagnosed GB malignancies. The most common origin was the stomach. The median survival of MGB was 8.7 mo.
AIM: To evaluate the clinicopathologic characteristics of patients with metastases to the gallbladder (MGBs). METHODS: We performed a single-center retrospective study of 20 patients with MGBs diagnosed pathologically from 1999 to 2007. RESULTS: Among 417 gallbladder (GB) malignancies, 20 (4.8%) were MGBs. The primary malignancies originated from the stomach (n = 8), colorectum (n = 3), liver (n = 2), kidney (n = 2), skin (n = 2), extrahepatic bile duct (n = 1), uterine cervix (n = 1), and appendix (n = 1). Twelve patients were diagnosed metachronously, presenting with cholecystitis (n = 4), abdominal pain (n = 2), jaundice (n = 1), weight loss (n = 1), and serum CA 19-9 elevation (n = 1); five patients were asymptomatic. The median survival after the diagnosis of MGB was 8.7 mo. On Cox regression analysis, R0 resection was the only factor associated with a prolonged survival [hazard ratio (HR): 0.01, P = 0.002]; presentation with cholecystitis was associated with poor survival (HR: 463.27, P = 0.006). CONCLUSION:MGBs accounted for 4.8% of all pathologically diagnosed GB malignancies. The most common origin was the stomach. The median survival of MGB was 8.7 mo.
Authors: Steven C Katz; Wilbur B Bowne; Jedd D Wolchok; Klaus J Busam; David P Jaques; Daniel G Coit Journal: Am J Surg Date: 2007-04 Impact factor: 2.565
Authors: L Weiss; J P Harlos; J Torhorst; B Gunthard; F Hartveit; E Svendsen; W L Huang; E Grundmann; M Eder; M Zwicknagl Journal: J Cancer Res Clin Oncol Date: 1988 Impact factor: 4.553
Authors: Flora Zagouri; Theodoros N Sergentanis; Dimitra Koulocheri; Afroditi Nonni; Aggeliki Bousiotou; Philip Domeyer; Nikolaos V Michalopoulos; Dimitrios Dardamanis; Manousos M Konstadoulakis; George C Zografos Journal: World J Surg Oncol Date: 2007-09-11 Impact factor: 2.754
Authors: Andrea Boscà Robledo; Sebastián Barber Millet; Juan F Orbis Castellanos; Eva M Montalvá Orón; Jose V Salom Fuster; Manuel DE Juan Burgueño Journal: Oncol Lett Date: 2012-02-22 Impact factor: 2.967
Authors: Won Seok Choi; Se Hyung Kim; Eun Sun Lee; Kyoung-Bun Lee; Won Jae Yoon; Cheong-Il Shin; Joon Koo Han Journal: Korean J Radiol Date: 2014-04-29 Impact factor: 3.500